Health Topics

Treatment with tocilizumab in patients with kidney transplant reduces mortality from COVID-19

In a retrospective study with 80 kidney transplant patients with COVID-19, treatment with tocilizumab demonstrates a decrease in one of the inflammation markers (the protein PCR) is associated with greater chances of survival.

Picture: Francisco Avia